Revolution Medicines, Inc. (RVMD) FY2025 Annual Balance Sheet

Balance Sheet

As of 2025-12-31

Swipe to see the full flow
Revolution Medicines, Inc. (RVMD) FY2025 Annual Balance SheetBalance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.Current liabilities$290.42 MLiabilities$723.21 MNon-current liabilities$432.79 MCurrent assets$2.08 BEquity$1.63 BAssets$2.35 BGross equity(calculated)$4.50 BNon-current assets$279.47 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSMarketable securitiesCash and cash equivalentsPrepaid expenses and other current assetsOperating lease right-of-use assetIntangible assets, netProperty and equipment, netLong-term depositsOther noncurrent assetsGoodwillRestricted cashAccrued expenses and other current liabilitiesAccounts payableOperating lease liability, currentLiability related to the sale of future royaltiesOperating lease liability, noncurrentWarrant liabilityDeferred tax liabilityOther noncurrent liabilitiesAdditional paid-in capitalAccumulated other comprehensive incomeCommon stock, $0.0001 par value; 300,000,000 shares authorized as of December 31, 2025 and December 31, 2024, respectively; 197,001,401 and 185,896,625 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitCurrent liabilitiesCurrent liabilities$290.42 MAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$209.34 MAccounts payableAccounts payable$64.62 MLiabilitiesLiabilities$723.21 MOperating lease liability, currentOperating lease liability, current$16.47 MLiability related to the sale of future royaltiesLiability related to the sale of future royalties$268.45 MNon-current liabilitiesNon-current liabilities$432.79 MCurrent assetsCurrent assets$2.08 BOperating lease liability, noncurrentOperating lease liability, noncurrent$142.23 MWarrant liabilityWarrant liability$18.55 MDeferred tax liabilityDeferred tax liability$2.35 MEquityEquity$1.63 BMarketable securitiesMarketable securities$1.64 BOther noncurrent liabilitiesOther noncurrent liabilities$1.21 MAssetsAssets$2.35 BGross equity (calculated)Gross equity(calculated)$4.50 BCash and cash equivalentsCash and cash equivalents$383.75 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$49.36 MOperating lease right-of-use assetOperating lease right-of-use asset$132.08 MIntangible assets, netIntangible assets, net$55.80 MNon-current assetsNon-current assets$279.47 MProperty and equipment, netProperty and equipment, net$33.19 MAdditional paid-in capitalAdditional paid-in capital$4.50 BLong-term depositsLong-term deposits$24.15 MOther noncurrent assetsOther noncurrent assets$14.78 MGoodwillGoodwill$14.61 MRestricted cashRestricted cash$4.86 MAccumulated other comprehensive incomeAccumulated other comprehensive income$3.24 MCommon stock, $0.0001 par value; 300,000,000 shares authorized as of December 31, 2025 and December 31, 2024, respectively; 197,001,401 and 185,896,625 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectivelyCommon stock$19.00 KAccumulated deficitAccumulated deficit−$2.87 B
Chart details

Revolution Medicines, Inc. (RVMD) FY2025 Annual Balance Sheet

Balance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.

Assets
2,354,508,000 US dollars
Current assets
2,075,037,000 US dollars
Non-current assets
279,471,000 US dollars
Liabilities
723,211,000 US dollars
Current liabilities
290,424,000 US dollars
Non-current liabilities
432,787,000 US dollars
Equity
1,631,297,000 US dollars
Marketable securities
1,641,934,000 US dollars
Cash and cash equivalents
383,745,000 US dollars
Prepaid expenses and other current assets
49,358,000 US dollars
Operating lease right-of-use asset
132,084,000 US dollars
Intangible assets, net
55,800,000 US dollars
Property and equipment, net
33,194,000 US dollars
Long-term deposits
24,148,000 US dollars
Other noncurrent assets
14,779,000 US dollars
Goodwill
14,608,000 US dollars
Restricted cash
4,858,000 US dollars
Accrued expenses and other current liabilities
209,340,000 US dollars
Accounts payable
64,616,000 US dollars
Operating lease liability, current
16,468,000 US dollars
Liability related to the sale of future royalties
268,446,000 US dollars
Operating lease liability, noncurrent
142,234,000 US dollars
Warrant liability
18,546,000 US dollars
Deferred tax liability
2,353,000 US dollars
Other noncurrent liabilities
1,208,000 US dollars
Additional paid-in capital
4,497,143,000 US dollars
Accumulated other comprehensive income
3,237,000 US dollars
Common stock, $0.0001 par value; 300,000,000 shares authorized as of December 31, 2025 and December 31, 2024, respectively; 197,001,401 and 185,896,625 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively
19,000 US dollars
Preferred stock, $0.0001 par value; 10,000,000 shares authorized at December 31, 2025 and December 31, 2024, respectively; none issued and outstanding at December 31, 2025 and December 31, 2024, respectively
0 US dollars
Accumulated deficit
negative 2,869,102,000 US dollars
Gross equity (calculated)
4,500,399,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Revolution Medicines, Inc. (RVMD) FY2025 Annual Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!